Vet World   Vol.18   November-2025  Article - 7 

Research Article

Veterinary World, 18(11): 3378-3389

https://doi.org/10.14202/vetworld.2025.3378-3389

Development and validation of a recombinant capsid protein-based indirect enzyme-linked immunosorbent assay for serological detection of duck circovirus in commercial flocks

Thnapol Luengyosluechakul1, Sittinee Kulprasertsri2, Siriluk Jala3, Sakuna Phatthanakunanan3, and Preeda Lertwatcharasarakul4

1. Animal Health and Biomedical Sciences Study Program, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand.

2. Department of Farm Resources and Production Medicine, Faculty of Veterinary Medicine, Kasetsart University, Nakhon Pathom 73140, Thailand.

3. Kamphaeng Sean Veterinary Diagnostic Center, Faculty of Veterinary Medicine, Kasetsart University, Nakhon Pathom 73140, Thailand.

4. Department of Pathology, Faculty of Veterinary Medicine, Kasetsart University, Nakhon Pathom 73140, Thailand.

Background and Aim: Duck circovirus (DuCV) is an immunosuppressive pathogen linked to poor growth, feather abnormalities, and increased susceptibility to co-infections, leading to significant economic losses in duck production. Rapid and large-scale serological screening tools are essential for epidemiological surveillance and biosecurity. This study aimed to develop and validate an indirect enzyme-linked immunosorbent assay (iELISA) based on a recombinant capsid (Cap) protein for sensitive and specific detection of antibodies against DuCV.

Materials and Methods: The cap gene from a Thai DuCV genotype I isolate was cloned into the pQE-31 vector and expressed in Escherichia coli M15. The 27 kDa recombinant Cap protein was purified under denaturing conditions, and its antigenicity was confirmed by Western blotting. The iELISA was optimized by checkerboard titration to determine the optimal antigen coating concentration and serum dilution. Diagnostic sensitivity, specificity, cross-reactivity, repeatability, reproducibility, and agreement with Western blotting were assessed using 80 positive, 103 negative, and 189 field serum samples.

Results: The optimized iELISA used 12 μg/well of antigen and a 1:20 serum dilution, producing the highest positive-to-negative optical density ratio. Receiver operating characteristic curve analysis yielded an area under the curve of 0.996, with 97.5% sensitivity and 98.1% specificity. No cross-reactivity was detected with sera positive for duck Tembusu virus, duck viral enteritis virus, or Riemerella anatipestifer. Intra- and inter-assay coefficients of variation were below 6.5% and 9.1%, respectively. Diagnostic agreement with Western blotting across 189 field sera was 91.0%, with a Cohen’s kappa of 0.752, indicating substantial concordance.

Conclusion: The developed recombinant Cap-based iELISA provides a reliable, specific, and reproducible tool for large-scale DuCV serosurveillance. Its high diagnostic accuracy and scalability support its application in flock-level monitoring, pre-movement screening, and epidemiological studies, facilitating improved biosecurity and informed disease control strategies within the duck industry.

Keywords: capsid protein, duck circovirus, indirect enzyme-linked immunosorbent assay, recombinant protein, serodiagnosis.

How to cite this article: Luengyosluechakul T, Kulprasertsri S, Jala S, Phatthanakunanan S, and Lertwatcharasarakul P (2025) Development and validation of a recombinant capsid protein-based indirect enzyme-linked immunosorbent assay for serological detection of duck circovirus in commercial flocks. Veterinary World, 18(11): 3378-3389.

Received: 19-06-2025   Accepted: 13-10-2025   Published online: 06-11-2025

Corresponding author: Preeda Lertwatcharasarakul    E-mail: preeda.le@ku.th

DOI: 10.14202/vetworld.2025.3378-3389

Copyright: Luengyosluechakul, et al. This article is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.